179 related articles for article (PubMed ID: 11481522)
1. Alterations of mismatch repair protein expression in benign melanocytic nevi, melanocytic dysplastic nevi, and cutaneous malignant melanomas.
Hussein MR; Roggero E; Sudilovsky EC; Tuthill RJ; Wood GS; Sudilovsky O
Am J Dermatopathol; 2001 Aug; 23(4):308-14. PubMed ID: 11481522
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity, microsatellite instability, and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas.
Hussein MR; Sun M; Roggero E; Sudilovsky EC; Tuthill RJ; Wood GS; Sudilovsky O
Mol Carcinog; 2002 May; 34(1):35-44. PubMed ID: 12112321
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of the DNA mismatch repair proteins hMLH1 and hMSH2 in cutaneous dysplastic nevi and malignant melanoma.
Shpitz B; Klein E; Malinger P; Osmolovsky G; Gochberg S; Bomstein Y; Bernheim J
Int J Biol Markers; 2005; 20(1):65-8. PubMed ID: 15832775
[TBL] [Abstract][Full Text] [Related]
4. Mismatch repair protein expression and microsatellite instability: a comparison of clear cell sarcoma of soft parts and metastatic melanoma.
Garcia JJ; Kramer MJ; O'Donnell RJ; Horvai AE
Mod Pathol; 2006 Jul; 19(7):950-7. PubMed ID: 16619000
[TBL] [Abstract][Full Text] [Related]
5. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi.
Hussein MR; Sun M; Tuthill RJ; Roggero E; Monti JA; Sudilovsky EC; Wood GS; Sudilovsky O
J Cutan Pathol; 2001 Aug; 28(7):343-50. PubMed ID: 11437939
[TBL] [Abstract][Full Text] [Related]
7. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D
Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
[TBL] [Abstract][Full Text] [Related]
8. IMP-3 EXPRESSION IN BENIGN MELANOCYTIC NEVI, DYSPLASTIC NEVI AND MALIGNANT MELANOMA: PRELIMINARY FINDINGS IN BULGARIAN PATIENTS.
Chokoeva AA; Ananiev J; Wollina U; Tana C; Lotti T; Cardoso JC; Tchernev G
J Biol Regul Homeost Agents; 2015; 29(3):695-9. PubMed ID: 26403409
[TBL] [Abstract][Full Text] [Related]
9. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.
Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB
Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550
[TBL] [Abstract][Full Text] [Related]
10. Expression of the embryonic morphogen Nodal in cutaneous melanocytic lesions.
Yu L; Harms PW; Pouryazdanparast P; Kim DS; Ma L; Fullen DR
Mod Pathol; 2010 Sep; 23(9):1209-14. PubMed ID: 20495543
[TBL] [Abstract][Full Text] [Related]
11. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
12. The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions.
Lebe B; Pabuççuoğlu U; Ozer E
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):160-4. PubMed ID: 17525627
[TBL] [Abstract][Full Text] [Related]
13. DNA mismatch repair protein expression and microsatellite instability in primary mucosal melanomas of the head and neck.
Marani C; Alvino E; Caporali S; Vigili MG; Mancini G; Rahimi S
Histopathology; 2007 May; 50(6):780-8. PubMed ID: 17493242
[TBL] [Abstract][Full Text] [Related]
14. DNA mismatch repair enzyme hMSH2 in malignant melanoma: increased immunoreactivity as compared to acquired melanocytic nevi and strong mRNA expression in melanoma cell lines.
Rass K; Gutwein P; Welter C; Meineke V; Tilgen W; Reichrath J
Histochem J; 2001 Aug; 33(8):459-67. PubMed ID: 11931386
[TBL] [Abstract][Full Text] [Related]
15. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
16. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions.
Wang H; Shen SS; Wang H; Diwan AH; Zhang W; Fuller GN; Prieto VG
J Cutan Pathol; 2003 Nov; 30(10):599-605. PubMed ID: 14744083
[TBL] [Abstract][Full Text] [Related]
17. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
Mehregan DR; Hamzavi I
Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of DNA mismatch repair protein and O6-methylguanine-DNA methyltransferase in melanoma metastases in relation to clinical response to DTIC-based chemotherapy.
Ma S; Egyházi S; Ringborg U; Hansson J
Oncol Rep; 2002; 9(5):1015-9. PubMed ID: 12168066
[TBL] [Abstract][Full Text] [Related]
19. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas TM; English DR; Heenan PJ
J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability and alterations of mismatch repair protein expression in choroidal melanomas.
Hussein MR; Haemel AK; Albert DM; Wood GS
Arch Ophthalmol; 2005 Dec; 123(12):1705-11. PubMed ID: 16344443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
